GLOBEALERT
Business● LowSep 23 · Sep 23, 2026, 10:18 AM

BoomRay and Novartis Pharma sign $900m deal for radioligand therapy

GlobeAlert Desk · curated from Yahoo Finance · global

BoomRay and Novartis Pharma have signed a $900 million deal concerning radioligand therapy. This represents a significant business transaction in the pharmaceutical industry.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level
1 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources
1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

Category
Business

Not flagged as developing.

More in Business